209 related articles for article (PubMed ID: 18055394)
21. Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.
Goday A; Barneto I; García-Almeida JM; Blasco A; Lecube A; Grávalos C; Martínez de Icaya P; de las Peñas R; Monereo S; Vázquez L; Palacio JE; Pérez-Segura P
Clin Transl Oncol; 2015 Oct; 17(10):763-71. PubMed ID: 26036853
[TBL] [Abstract][Full Text] [Related]
22. Obesity and metabolic syndrome as related to cardiovascular disease.
Nikolopoulou A; Kadoglou NP
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
[TBL] [Abstract][Full Text] [Related]
23. Obesity and metabolic syndrome: an inflammatory condition.
Scarpellini E; Tack J
Dig Dis; 2012; 30(2):148-53. PubMed ID: 22722429
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hyperinsulinism, type 2 diabetes mellitus and metabolic syndrome among Saudi overweight and obese pediatric patients.
Al-Agha A; Ocheltree A; Shata N
Minerva Pediatr; 2012 Dec; 64(6):623-31. PubMed ID: 23108324
[TBL] [Abstract][Full Text] [Related]
25. Obesity-driven inflammation and colorectal cancer.
Vazzana N; Riondino S; Toto V; Guadagni F; Roselli M; Davi G; Ferroni P
Curr Med Chem; 2012; 19(34):5837-53. PubMed ID: 23033947
[TBL] [Abstract][Full Text] [Related]
26. Obesity and bowel cancer: from molecular mechanisms to interventions.
Mathers JC
Nutr Res; 2019 Oct; 70():26-31. PubMed ID: 30274687
[TBL] [Abstract][Full Text] [Related]
27. Current perspectives between metabolic syndrome and cancer.
Micucci C; Valli D; Matacchione G; Catalano A
Oncotarget; 2016 Jun; 7(25):38959-38972. PubMed ID: 27029038
[TBL] [Abstract][Full Text] [Related]
28. Overweight, obesity and metabolic alterations in chronic kidney disease.
Zoccali C
Prilozi; 2009 Dec; 30(2):17-31. PubMed ID: 20087247
[TBL] [Abstract][Full Text] [Related]
29. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study.
Stürmer T; Buring JE; Lee IM; Gaziano JM; Glynn RJ
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2391-7. PubMed ID: 17164361
[TBL] [Abstract][Full Text] [Related]
30. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
[TBL] [Abstract][Full Text] [Related]
31. Diabetes and cancer: two diseases with obesity as a common risk factor.
Garg SK; Maurer H; Reed K; Selagamsetty R
Diabetes Obes Metab; 2014 Feb; 16(2):97-110. PubMed ID: 23668396
[TBL] [Abstract][Full Text] [Related]
32. [The metabolic syndrome and insulin resistance].
Kotani K; Kaku K
Nihon Rinsho; 2005 Aug; 63(8):1485-91. PubMed ID: 16101244
[TBL] [Abstract][Full Text] [Related]
33. Obesity: an epidemiological perspective from Asia and its relationship to gastrointestinal and liver cancers.
Goh LY; Goh KL
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():54-8. PubMed ID: 24251705
[TBL] [Abstract][Full Text] [Related]
34. [Obesity and colorectal cancer].
Na SY; Myung SJ
Korean J Gastroenterol; 2012 Jan; 59(1):16-26. PubMed ID: 22289950
[TBL] [Abstract][Full Text] [Related]
35. Association between obesity and gallbladder cancer.
Wang F; Wang B; Qiao L
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2550-8. PubMed ID: 22652797
[TBL] [Abstract][Full Text] [Related]
36. Obesity, insulin resistance and cancer risk.
Jee SH; Kim HJ; Lee J
Yonsei Med J; 2005 Aug; 46(4):449-55. PubMed ID: 16127767
[TBL] [Abstract][Full Text] [Related]
37. Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment.
Takahashi H; Yoneda K; Tomimoto A; Endo H; Fujisawa T; Iida H; Mawatari H; Nozaki Y; Ikeda T; Akiyama T; Yoneda M; Inamori M; Abe Y; Saito S; Nakajima A; Nakagama H
J Pharmacol Sci; 2007 Oct; 105(2):129-32. PubMed ID: 17928742
[TBL] [Abstract][Full Text] [Related]
38. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
Hagymási K; Reismann P; Rácz K; Tulassay Z
Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
[TBL] [Abstract][Full Text] [Related]
39. Hyperinsulinemia in Obesity, Inflammation, and Cancer.
Zhang AMY; Wellberg EA; Kopp JL; Johnson JD
Diabetes Metab J; 2021 May; 45(3):285-311. PubMed ID: 33775061
[TBL] [Abstract][Full Text] [Related]
40. Obesity and cancer: local and systemic mechanisms.
Iyengar NM; Hudis CA; Dannenberg AJ
Annu Rev Med; 2015; 66():297-309. PubMed ID: 25587653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
